With no cure, Parkinson’s disease represents a long-term degenerative disorder stemming from the central nervous system. With symptoms that typically come on slowly, they progress…
Steve Kirsch, founder of the COVID-19 Early Treatment Fund (CETF) discussed the evidence backing fluvoxamine as a treatment for COVID-19.
The use of artificial intelligence (AI), including machine learning technology, spurs growing investor appetite for investment in life science-based research, particularly in the critical area…
A physician critical of the COVID-19 vaccination program in India has filed an action with the Supreme Court of India in an effort to make…
Washington University in St. Louis received a $1.4 million grant from the National Institutes of Health (NIH) Community Engagement Alliance (CEAL) Against COVID-19 Disparities; funds…
Covid-19 Outbreak in India: Initial Review of the Data and the India Solution. So, The whole world has been watching India lately. Just a matter…
American Skin Association has announced the awarding of two coveted research grants under the ASA Milstein Research Scholar Awards program. Andrew Ji, MD of the…
A recent poll sponsored by the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health found that a majority of Americans don’t really…
The Cleveland Clinic conducted a study recently, revealing that of the 4,300 COVID-19 admissions from January through mid-April, about 99% of these patients were not…
Stanford Medicine is the latest trial site to announce participation in the Pfizer vaccine nationwide clinical trial targeting children under 12 years of age. This…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
